OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000422$15.4058

Hubei Yihua Chemical Industry Co Ltd

Diversified ChemicalsVerified

Capital Structure and Liquidity Hubei Yihua Chemical Industry Co Ltd has a market capitalization of CNY 16.75 billion and a price-to-book ratio of 2.46, indicating a premium valuation relative to its book value. The company's liquidity position is assessed as medium, with a current ratio of 0.62, suggesting limited short-term liquidity to cover immediate liabilities. Free cash flow is negative at CNY -1.58 billion, and capital expenditures are substantial at CNY -4.80 billion, indicating ongoing investment in operations. ### Profitability and Returns The company's return on equity (ROE) is 11.89%, which is relatively strong, but its return on assets (ROA) is only 1.76%, indicating that the company is not efficiently utilizing its assets to generate returns. The price-to-earnings ratio of 20.71 suggests that the stock is trading at a premium to earnings, which may reflect investor optimism about future growth. ### Segments and Geographic Exposure The company operates as a single segment, with no disclosed geographic breakdown of revenue. This lack of segmentation data limits the ability to assess geographic diversification and potential concentration risks. ### Growth Trajectory The company's revenue for the latest period is CNY 25.65 billion, with a gross profit of CNY 4.30 billion. While the company has a strong revenue base, the operating income of CNY 1.31 billion and net income of CNY 0.81 billion suggest that profitability is constrained by high operating costs. Analysts have set a mean price target of CNY 17.13, indicating a potential upside of 11.2% from the current market price of CNY 15.40. ### Risk Factors The company faces a medium liquidity risk, with a current ratio of 0.62 and a negative net cash position after subtracting total debt. The debt-to-equity ratio is 3.42, indicating a high level of leverage, which could increase financial risk during periods of economic stress. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. ### Recent Events Recent financial filings and transcripts do not indicate any major events that would significantly impact the company's operations or financial position.

30-day price · 000422-1.59 (-9.9%)
Low$14.39High$17.40Close$14.41As of22 May, 00:00 UTC
Profile
CompanyHubei Yihua Chemical Industry Co Ltd
Ticker000422.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Hubei Yihua Chemical Industry Co Ltd is a diversified chemicals company engaged in the production and sale of chemical products, primarily serving industrial and consumer markets.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry with a confidence level of 0.92.

### Capital Structure and Liquidity Hubei Yihua Chemical Industry Co Ltd has a market capitalization of CNY 16.75 billion and a price-to-book ratio of 2.46, indicating a premium valuation relative to its book value. The company's liquidity position is assessed as medium, with a current ratio of 0.62, suggesting limited short-term liquidity to cover immediate liabilities. Free cash flow is negative at CNY -1.58 billion, and capital expenditures are substantial at CNY -4.80 billion, indicating ongoing investment in operations. ### Profitability and Returns The company's return on equity (ROE) is 11.89%, which is relatively strong, but its return on assets (ROA) is only 1.76%, indicating that the company is not efficiently utilizing its assets to generate returns. The price-to-earnings ratio of 20.71 suggests that the stock is trading at a premium to earnings, which may reflect investor optimism about future growth. ### Segments and Geographic Exposure The company operates as a single segment, with no disclosed geographic breakdown of revenue. This lack of segmentation data limits the ability to assess geographic diversification and potential concentration risks. ### Growth Trajectory The company's revenue for the latest period is CNY 25.65 billion, with a gross profit of CNY 4.30 billion. While the company has a strong revenue base, the operating income of CNY 1.31 billion and net income of CNY 0.81 billion suggest that profitability is constrained by high operating costs. Analysts have set a mean price target of CNY 17.13, indicating a potential upside of 11.2% from the current market price of CNY 15.40. ### Risk Factors The company faces a medium liquidity risk, with a current ratio of 0.62 and a negative net cash position after subtracting total debt. The debt-to-equity ratio is 3.42, indicating a high level of leverage, which could increase financial risk during periods of economic stress. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. ### Recent Events Recent financial filings and transcripts do not indicate any major events that would significantly impact the company's operations or financial position.
Key takeaways
  • Hubei Yihua Chemical Industry Co Ltd has a strong ROE of 11.89% but a weak ROA of 1.76%, indicating inefficiency in asset utilization.
  • The company's liquidity position is medium, with a current ratio of 0.62 and a negative net cash position.
  • The stock is trading at a price-to-earnings ratio of 20.71, suggesting a premium valuation.
  • Analysts have set a mean price target of CNY 17.13, indicating a potential upside of 11.2%.
  • The company's high debt-to-equity ratio of 3.42 suggests a significant level of financial leverage.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$25.65B
Gross profit$4.30B
Operating income$1.31B
Net income$808.6M
R&D
SG&A
D&A
SBC
Operating cash flow$3.61B
CapEx-$4.80B
Free cash flow-$1.58B
Total assets$45.99B
Total liabilities$39.19B
Total equity$6.80B
Cash & equivalents
Long-term debt$23.29B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$25.65B$1.31B$808.6M-$1.58B
FY-1$25.39B$2.14B$1.07B-$3.70B
FY-2$17.04B$947.5M$453.1M-$214.2M
FY-3$20.71B$2.94B$2.16B$1.24B
FY-4$18.54B$2.20B$1.57B$1.66B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$45.99B$6.80B
FY-1$44.25B$8.48B$5.63B
FY-2$21.43B$6.57B
FY-3$19.67B$4.68B
FY-4$20.87B$2.41B
PeriodOCFCapExFCFSBC
FY0$3.61B-$4.80B-$1.58B
FY-1$4.42B-$5.95B-$3.70B
FY-2$1.63B-$1.75B-$214.2M
FY-3$3.86B-$2.24B$1.24B
FY-4$3.66B-$969.5M$1.66B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$6.76B$329.2M$181.1M
FQ-1$6.49B$235.1M-$3.0M
FQ-2$7.16B$464.3M$412.7M
FQ-3$8.06B$730.9M$364.9M
FQ-4$5.87B$377.0M$133.0M
FQ-5$5.58B$269.7M$1.1M
FQ-6$6.62B$516.0M$355.1M
FQ-7$8.99B$1.14B$574.5M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$47.06B$7.02B$4.14B
FQ-1$45.99B$6.80B
FQ-2$45.04B$5.90B$3.38B
FQ-3$44.31B$5.45B
FQ-4$26.59B$7.42B$2.00B
FQ-5$44.25B$8.48B$5.63B
FQ-6$24.89B$7.40B$3.89B
FQ-7$23.31B$7.20B$865.2M
PeriodOCFCapExFCFSBC
FQ0$948.6M-$915.1M
FQ-1$3.61B-$4.80B
FQ-2$3.12B-$3.46B
FQ-3$1.29B-$2.65B
FQ-4$428.0M-$1.66B
FQ-5$4.42B-$5.95B
FQ-6$3.22B-$3.99B
FQ-7$2.16B-$1.90B
Valuation
Market price$15.40
Market cap$16.75B
Enterprise value$40.04B
P/E20.7
Reported non-GAAP P/E
EV/Revenue1.6
EV/Op income30.5
EV/OCF11.1
P/B2.5
P/Tangible book2.5
Tangible book$6.80B
Net cash-$23.29B
Current ratio0.6
Debt/Equity3.4
ROA1.8%
ROE11.9%
Cash conversion4.5%
CapEx/Revenue-18.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
Metric000422Activity
Op margin5.1%-1.1% medp25 -1.1% · p75 -1.1%top quartile
Net margin3.2%-6.6% medp25 -6.6% · p75 -6.6%top quartile
Gross margin16.8%12.9% medp25 12.9% · p75 12.9%top quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-18.7%-7.1% medp25 -12.7% · p75 -4.4%bottom quartile
Debt / equity342.0%1639.6% medp25 1639.6% · p75 1639.6%bottom quartile
Observations
IR observations
Mean price target17.13 CNY
Median price target17.13 CNY
High price target17.76 CNY
Low price target16.50 CNY
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count3.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.89 CNY
Last actual EPS0.74 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 02:36 UTCJob: bfc29413